-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Reports $162,200 Common Share Disposal

PUBT·11/12/2026 23:02:11
Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Reports $162,200 Common Share Disposal
  • Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 811 common shares at $200 each on Nov. 9, 2026.
  • He exercised stock options for 810 shares at $33.62 each and one share at $102.02.
  • His direct beneficial ownership totaled 39,765 common shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-458844), on November 12, 2026, and is solely responsible for the information contained therein.